Literature DB >> 9817321

Venous patch graft for Peyronie's disease. Part II: outcome analysis.

A I El-Sakka1, H M Rashwan, T F Lue.   

Abstract

PURPOSE: We evaluate the results of tunical incision and venous patch grafting for correcting penile deformity in Peyronie's disease.
MATERIALS AND METHODS: In 113 [corrected] patients with symptoms of Peyronie's disease for more than a year indications for surgery included penile shortening, persistent pain, severe curvature, penile narrowing or indentation and/or failure of previous surgery. Preoperative evaluation included determination of patient and partner expectation, potency status, circumcision status, measurement of penile length (short and long side) and saphenous vein, and color duplex ultrasonography to evaluate possible accessory vascular communication. Patients underwent plaque incision and venous patch grafting. The configuration, size and number of tunical incisions depended on the size and shape of the lesion. Lower and upper saphenous, and deep dorsal veins served as the graft materials. Postoperative followup was as long as 18 months.
RESULTS: In 96% of patients the penis became straight, while residual curvature was 30 degrees in 3% and 15 degrees in 1%. In 94% of patients narrowing and indentation were absent and in 83% penile length was the same or longer postoperatively. Of the patients who were potent preoperatively 88% experienced the same or better erectile quality after surgery. In 10% of cases a change in sensation occurred lasting longer than 6 months. Overall satisfaction was expressed by 92% of men who believed that surgery improved the psychological state as well as the relationship with the partner.
CONCLUSIONS: The results are satisfactory and this procedure offers a reasonable solution for correction of Peyronie's disease.

Entities:  

Mesh:

Year:  1998        PMID: 9817321     DOI: 10.1097/00005392-199812010-00030

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

1.  A novel approach for the surgical management of Peyronie's disease using an acellular, human dermis tissue graft: preliminary results.

Authors:  Ioannis Adamakis; Stavros I Tyritzis; Konstantinos G Stravodimos; Vasileios Migdalis; Dionysios Mitropoulos; Constantinos A Constantinides
Journal:  World J Urol       Date:  2010-10-06       Impact factor: 4.226

2.  Plaque incision and venous patch grafting for Peyronie's disease.

Authors:  Ahmet Metin; Onder Kayigil; S Iftekhar Ahmed
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 3.  Treatment of Peyronie's disease: 2012 update.

Authors:  Ege Can Serefoglu; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

4.  2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature.

Authors:  Anthony J Bella; Jay C Lee; Ethan D Grober; Serge Carrier; Francois Benard; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2018-02-22       Impact factor: 1.862

5.  Penile Sensory Changes After Plaque Incision and Grafting Surgery for Peyronie's Disease.

Authors:  Jean E Terrier; Raanan Tal; Christian J Nelson; John P Mulhall
Journal:  J Sex Med       Date:  2018-09-06       Impact factor: 3.802

6.  Peyronie's Disease: A Review.

Authors:  Mark Jalkut; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Rev Urol       Date:  2003

Review 7.  Pharmacological Management of Peyronie's Disease.

Authors:  Landon W Trost; Serap Gur; Wayne J G Hellstrom
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Tunica-sparing ossified Peyronie's plaque excision.

Authors:  Michael L Eisenberg; James F Smith; Alan W Shindel; Tom F Lue
Journal:  BJU Int       Date:  2010-08-26       Impact factor: 5.588

Review 9.  Surgical management of erectile dysfunction.

Authors:  Aaron J Milbank; Drogo K Montague
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 10.  Surgery for Peyronie's disease.

Authors:  Laurence A Levine; Stephen M Larsen
Journal:  Asian J Androl       Date:  2012-11-26       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.